Leqembi, Biogen's Alzheimers drug that recently won full US FDA approval, is set to capture significant market share, according to a new physician survey from Baird.
https://seekingalpha.com/news/4005683-biogen-leqembi-alzheimers-strong-uptake-baird-physician-survey
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.